Physician profile
Andrew Thomas Vest
NPI 1548899305
$2,707.01
in general payments reported to CMS, 2019-2025
13 companies · $2,674 in 2025
The $2,674 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.92 · 2023: $20.29 · 2025: $2,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,666 · Travel and Lodging: $1,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,665.55 |
| Travel and Lodging | $1,028.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,178.86 | 2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbott Laboratories | $461.22 | 2025 | Proclaim |
| Stryker Corporation | $333.65 | 2025 | Mild Device Kit |
| Averitas Pharma INC. | $175.09 | 2025 | Qutenza |
| Cerapedics INC. | $154.54 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Vy Spine LLC | $148.71 | 2025 | |
| Bioventus LLC | $100.85 | 2025 | Durolane, Xcell |
| Globus Medical, INC. | $42.03 | 2025 | Vyrsa V1 |
| Nalu Medical, INC. | $31.14 | 2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $25.32 | 2025 | Wavewriter Alpha Prime 16 |
| Lundbeck LLC | $22.39 | 2025 | Vyepti |
| Chiesi USA, INC. | $20.29 | 2023 | Cleviprex |
| Lilly USA, LLC | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Vest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.